🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine the maximum tolerated dose (MTD) of arbaclofen pl...
Status
Completed
Location
Research Centers of America
Start Date
2015-09
Trial ID
NCT02511886
Treatments Being Tested
This is a single-site, randomized, acute dose-response study to determine w...
Status
Completed
Location
Children's Hospital of Phladelphia
Start Date
2016-02
Trial ID
NCT02278328
Treatments Being Tested
Study 22001, "A Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation ...
Status
Terminated
Location
University of California-Los Angeles Neuropsychiatric Institute
Start Date
2009-11
Trial ID
NCT01013480
Treatments Being Tested
To explore the efficacy, safety and tolerability of STX209 (arbaclofen) adm...
Status
Completed
Location
Southwest Autism Research & Resource Center
Start Date
2011-05
Trial ID
NCT01282268
Treatments Being Tested
This study will enroll subjects who have completed Protocols 209FX301, 209F...
Status
Terminated
Location
Seaside Therapeutics Site #16
Start Date
2011-11
Trial ID
NCT01555333
Treatments Being Tested
This study investigates the brain response to a single acute dose of Arbacl...
Status
Completed
Location
King's College London
Start Date
2018-02-01
Trial ID
NCT03594552
Treatments Being Tested
The purpose of the study is to evaluate safety and tolerability of arbaclof...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00817986
Treatments Being Tested
This is an open-label extension protocol that will provide necessary data o...
Status
Terminated
Location
Southwest Autism Research & Resource Center
Start Date
2011-11
Trial ID
NCT01706523
Treatments Being Tested
This is a multicenter, randomized (1:1:1), double-blind, active and placebo...
Status
Completed
Location
Osmotica Study Site-138
Start Date
2012-11
Trial ID
NCT01743651
Treatments Being Tested
AIMS-2-CT-01 is a randomized, double-blind, placebo controlled, study to ex...
Status
Completed
Location
Robert Debré Hospital
Start Date
2019-09-19
Trial ID
NCT03682978
Treatments Being Tested